James Jenkins

Work

Karolinska Institutet

|

Postdoctoral Researcher

Sweden

→

Mayo Clinic

|

PhD Student

US

→

Mayo Clinic

|

PhD Student

US

→

Mayo Clinic

|

GREP Student (postbach position)

US

→

Education

Mayo Clinic

United States of America
→
PhD

Publications

MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigens

Journal for ImmunoTherapy of Cancer

journal-article

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.

Journal for immunotherapy of cancer

journal-article

The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality.

Immunity

journal-article